Chemotherapy Market Segmentation by Cancer Type (Lung, Breast, Stomach, and Ovarian Cancer, and Others); by Gender Type (Male, and Female); and by Product Type (Pump, Cannula, Catheter, and Others)-Global Demand Analysis & Opportunity Outlook 2022-2031
-
Product Code:
RP-ID-10094818 -
Published Date:
21 Oct 2022 -
Region:
Global
-
Category:
Healthcare & Pharmaceuticals -
Publisher:
Pub-ID-54
Impact Analysis on the Growth of Market
Inflation and Looming Recession to Haunt Businesses:
In 2022 & 2023, market players expected to sail in rough waters; might incur losses due to huge gap in currency translation followed by contracting revenues, shrinking profit margins & cost pressure on logistics and supply chain. Further, U.S. economy is expected to grow merely by 3% in 2022.
....
The Research Report is Updated with 2022 Base Year, 2023 Estimated year and Forecast till 2035 with Market Insights.
With the dip in global production, the GDP has contracted in 2020 and impacted the market across the world. Upon placing a Sample Request, you will receive an updated report with 2022 as base year, 2023 as estimated year and forecast to 2035. This will have market drivers, recovery rate in the market, insights and competitive analysis.
Market Overview:
Translate Report
Global Chemotherapy Market Highlights Over 2022 - 2031
The global chemotherapy market is estimated to grow at a notable CAGR over the forecast period, i.e., 2022–2031. Moreover, in the year 2021, the market registered a remarkable revenue. The growth of the market can be attributed to the rising cancer cases and the increasing population. For instance, according to a report by the World Health Organisation, worldwide, the second leading reason for mortality is cancer that, accounted for approximately 9.6 million deaths in 2018. Additionally, the increase in expenditure on medicine and research and development are some of the major factors expected to boost the growth of the global chemotherapy market.
GET A SAMPLE COPY OF THIS REPORT
The global chemotherapy market is segmented by cancer type into the lung, stomach, ovarian, breast cancer, and others. Among these segments, the breast cancer segment in the global chemotherapy market is estimated to witness the highest growth over the forecast period. The growth of the segment can be attributed to the increasing awareness among people related to breast cancer. According to the World Cancer Research Fund, 2,261,419 new breast cases were reported in the year 2020, which constitutes the highest number in relation to other cancer types. Therefore, rising breast cancer cases are expected to increase the growth of the global chemotherapy market.
Global Chemotherapy Market Regional Synopsis
Regionally, the global chemotherapy market is segmented into five major regions, including North America, Europe, Asia Pacific, Latin America, and Middle East & Africa region. The Asia Pacific region in the global chemotherapy market is estimated to witness modest growth over the forecast period on the back of a rising population in the particular region. According to the World Bank, China and India are among the countries with the largest populations, having 1,411.0 and 1,380.0 million populations respectively, in 2020, and their numbers are increasing on a yearly basis. Additionally, the rising cancer awareness among the population and increasing expenditure on research related to cancer in this region is further expected to boost market growth.
Market Segmentation
Our in-depth analysis of the global chemotherapy market includes the following segments:
By Cancer Type
-
Lung Cancer
-
Breast Cancer
-
Stomach Cancer
-
Ovarian Cancer
-
Others
By Gender Type
-
Male
-
Female
By Product Type
-
Pump
-
Cannula
-
Catheter
-
Others
Growth Drivers and Challenges Impacting the Growth of the Global Chemotherapy Market
Growth Drivers
-
Increasing population
-
Increase in the expenditure on medicine and research
-
Increase in the awareness related to cancer
Challenges
-
High cost of the treatment
-
Lack of government support related to cancer treatments in the countries
Key Companies Dominating the Global Chemotherapy Market
Our report has covered detailed company profiling comprising company overview, business strategies, key product offerings, financial performance, key performance indicators, risk analysis, recent developments, regional presence, and SWOT analysis among other notable indicators for competitive positioning. Some of the prominent industry leaders in the global chemotherapy market that are included in our report are Amgen Inc., Pfizer Inc., ALMATICA PHARMA LLC., Bayer AG, Puma Biotechnology, Inc., Sanofi, Astellas Pharma Inc., CLOVIS ONCOLOGY, Novartis AG, BeiGene, Ltd., and others.
Latest Developments in the Global Chemotherapy Market:
6 January 2022: As a second or third line treatment, Tislelizumab manufactured by BeiGene, Ltd., has been approved by the China National Medical Products Administration(NMPA) for patients suffering from locally advanced or metastatic non-small cell lung cancer.
14 January 2021: FDA approves Pfizer’s XALKORI for use in children and young adults in case of the ALK-positive anaplastic large cell lymphoma.
Key Reasons to Buy Our Report
-
The report covers detailed analysis comprising market share attained by each market segment and its sub-segments.
-
It covers market dynamics including growth drivers, trends, potential opportunities, price trend analysis and challenges that impact the market growth.
-
The report includes detailed company profiles of the major players dominating the market.
-
We use effective research methodologies to calculate the market numbers and provide value-added assessment for overall growth.
-
We provide customized reports as per the clients’ requirement helping them to see possible and unexpected challenges and unforeseen opportunities in order to help them reach their goal.
Geography Analysis:
The report further discusses the market opportunity, compound annual growth rate (CAGR) growth rate, competition, new technology innovations, market players analysis, government guidelines, export and import (EXIM) analysis, historical revenues, future forecasts etc. in the following regions and/or countries:
- North America (U.S. & Canada) Market Size, Y-O-Y Growth, Market Players Analysis & Opportunity Outlook
- Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market Size, Y-O-Y Growth & Market Players Analysis & Opportunity Outlook
- Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC(Finland, Sweden, Norway, Denmark), Ireland, Switzerland, Austria, Poland, Turkey, Russia, Rest of Europe), Poland, Turkey, Russia, Rest of Europe) Market Size, Y-O-Y Growth Market Players Analys & Opportunity Outlook
- Asia-Pacific (China, India, Japan, South Korea, Singapore, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market Size, Y-O-Y Growth & Market Players Analysis & Opportunity Outlook
- Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa) Market Size, Y-O-Y Growth Market Players Analysis & Opportunity Outlook
.
FREQUENTLY ASKED QUESTIONS
Increasing population, increase in the expenditure on medicine and research and increase in the awareness related to cancer are the major factors driving the growth of the chemotherapy market.
The market is expected to rise at a notable CAGR over the forecast period, i.e., 2022-2031.
High cost of the treatment and lack of government support related to cancer treatments in the countries are estimated to hamper the market growth.
Asia Pacific region will provide more business opportunities for growth of chemotherapy market in future.
The major players in the market are Amgen Inc., Pfizer Inc., ALMATICA PHARMA LLC., Bayer AG, Puma Biotechnology, Inc., Sanofi, Astellas Pharma Inc., CLOVIS ONCOLOGY, Novartis AG, BeiGene, Ltd., and others.
The company profiles are selected based on the revenues generated from the product segment, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.
The market is segmented by cancer type, gender type, product type and by region.
The breast cancer segment in the chemotherapy market is anticipated to hold highest market size in value and is estimated to grow over the forecast period and display significant growth opportunities.
Please enter your personal details below
- Amgen Inc.
- Pfizer Inc.
- ALMATICA PHARMA LLC.
- Bayer AG
- Puma Biotechnology, Inc.
- Sanofi
- Astellas Pharma Inc.
- CLOVIS ONCOLOGY
- Novartis AG
- BeiGene, Ltd.